Leonard C. Glass

Leonard C. Glass

executive Unknown

Leonard C. Glass is the Senior Vice President of Global Medical Affairs at Eli Lilly, where he plays a crucial role in overseeing the medical strategies for the company's cardiometabolic health products. In the context of recent clinical studies, Glass highlighted the significance of the findings regarding the efficacy of tirzepatida (Mounjaro) compared to semaglutida (Ozempic and Wegovy) in treating obesity, emphasizing the importance of informed decision-making for healthcare professionals and patients.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Brazil Brazil: Leonard C. Glass is the senior vice president of global medical affairs at Lilly Cardiometabolic Health. 8

O Globo: Qual o melhor remédio para perder peso? Estudo aponta que Mounjaro é 47% mais eficaz que o Wegovy e Ozempic